{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:27:42Z","timestamp":1769844462077,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100014189","name":"Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry","doi-asserted-by":"publisher","award":["121004-1"],"award-info":[{"award-number":["121004-1"]}],"id":[{"id":"10.13039\/501100014189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11259-022-10000-1","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T11:03:35Z","timestamp":1664190215000},"page":"1363-1368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antiviral activity of canine interferon lambda 3 expressed using a recombinant adenovirus against canine coronavirus, canine parvovirus, and canine distemper virus"],"prefix":"10.1007","volume":"46","author":[{"given":"Dong-Hwi","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Jeong","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Hyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong-Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Seon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,26]]},"reference":[{"key":"10000_CR1","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.15252\/EMMM.202012465","volume":"12","author":"E Andreakos","year":"2020","unstructured":"Andreakos E, Tsiodras S (2020) COVID-19: lambda interferon against viral load and hyperinflammation. EMBO Mol Med 12:e12465. https:\/\/doi.org\/10.15252\/EMMM.202012465","journal-title":"EMBO Mol Med"},{"key":"10000_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.VETIMM.2008.09.023","volume":"127","author":"A Beineke","year":"2009","unstructured":"Beineke A, Puff C, Seehusen F, Baumg\u00e4rtner W (2009) Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol 127:1\u201318. https:\/\/doi.org\/10.1016\/J.VETIMM.2008.09.023","journal-title":"Vet Immunol Immunopathol"},{"issue":"3","key":"10000_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","volume":"18","author":"EC Borden","year":"2019","unstructured":"Borden EC (2019) Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights. Nat Rev Drug Discov 18(3):219\u2013234. https:\/\/doi.org\/10.1038\/s41573-018-0011-2","journal-title":"Nat Rev Drug Discov"},{"key":"10000_CR4","doi-asserted-by":"publisher","first-page":"A41","DOI":"10.1053\/EJPN.2002.0573","volume":"6","author":"M De Andrea","year":"2002","unstructured":"De Andrea M, Ravera R, Gioia D et al (2002) The interferon system: an overview. Eur J Paediatr Neurol 6:A41\u2013A46. https:\/\/doi.org\/10.1053\/EJPN.2002.0573","journal-title":"Eur J Paediatr Neurol"},{"key":"10000_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1006\/TAAP.2002.9372","volume":"180","author":"GW Demers","year":"2002","unstructured":"Demers GW, Sugarman BJ, Beltran JC et al (2002) Interferon-\u03b12b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles. Toxicol Appl Pharmacol 180:36\u201342. https:\/\/doi.org\/10.1006\/TAAP.2002.9372","journal-title":"Toxicol Appl Pharmacol"},{"key":"10000_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/J.IJBIOMAC.2019.03.161","volume":"131","author":"S Du","year":"2019","unstructured":"Du S, Jiang Y, Xu W et al (2019) Construction, expression and antiviral activity analysis of recombinant adenovirus expressing human IFITM3 in vitro. Int J Biol Macromol 131:925\u2013932. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2019.03.161","journal-title":"Int J Biol Macromol"},{"key":"10000_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-6148-10-23\/TABLES\/4","volume":"10","author":"ABDR Gizzi","year":"2014","unstructured":"Gizzi ABDR, Oliveira ST, Leutenegger CM et al (2014) Presence of infectious agents and co-infections in diarrheic dogs determined with a real-time polymerase chain reaction-based panel. BMC Vet Res 10:1\u20138. https:\/\/doi.org\/10.1186\/1746-6148-10-23\/TABLES\/4","journal-title":"BMC Vet Res"},{"key":"10000_CR8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.5530\/pj.2022.14.76","volume":"14","author":"IS Hamid","year":"2022","unstructured":"Hamid IS, Ekowati J, Solfaine R et al (2022) Efficacy of probiotic on duodenal TNF-\u03b1 expression and the histological findings in the liver and lung in animal model canine coronavirus. Pharmacogn J 14:591\u2013597. https:\/\/doi.org\/10.5530\/pj.2022.14.76","journal-title":"Pharmacogn J"},{"key":"10000_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/J.VIROL.2006.10.031","volume":"360","author":"JG Julander","year":"2007","unstructured":"Julander JG, Siddharthan V, Blatt LM et al (2007) Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology 360:454\u2013460. https:\/\/doi.org\/10.1016\/J.VIROL.2006.10.031","journal-title":"Virology"},{"key":"10000_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-01054-3","volume":"11","author":"DH Kim","year":"2021","unstructured":"Kim DH, Ahn HS, Go HJ et al (2021a) Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction. Sci Rep 11:1\u20139. https:\/\/doi.org\/10.1038\/s41598-021-01054-3","journal-title":"Sci Rep"},{"key":"10000_CR11","doi-asserted-by":"publisher","first-page":"198342","DOI":"10.1016\/J.VIRUSRES.2021.198342","volume":"296","author":"DH Kim","year":"2021","unstructured":"Kim DH, Park BJ, Ahn HS et al (2021b) Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus. Virus Res 296:198342. https:\/\/doi.org\/10.1016\/J.VIRUSRES.2021.198342","journal-title":"Virus Res"},{"key":"10000_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.ANTIVIRAL.2014.01.014","volume":"104","author":"SM Kim","year":"2014","unstructured":"Kim SM, Kim SK, Park JH et al (2014) A recombinant adenovirus bicistronically expressing porcine interferon-\u03b1 and interferon-\u03b3 enhances antiviral effects against foot-and-mouth disease virus. Antiviral Res 104:52\u201358. https:\/\/doi.org\/10.1016\/J.ANTIVIRAL.2014.01.014","journal-title":"Antiviral Res"},{"key":"10000_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.vetimm.2017.08.006","volume":"191","author":"D Klotz","year":"2017","unstructured":"Klotz D, Baumg\u00e4rtner W, Gerhauser I (2017) Type I interferons in the pathogenesis and treatment of canine diseases. Vet Immunol Immunopathol 191:80\u201393","journal-title":"Vet Immunol Immunopathol"},{"key":"10000_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.30954\/2277-940X.04.2020.29","volume":"10","author":"R Kumar","year":"2020","unstructured":"Kumar R (2020) Comparative evaluation of therapeutic modules for treatment of parvoviral gastroenteritis in dogs. J Anim Res 10:673\u2013676. https:\/\/doi.org\/10.30954\/2277-940X.04.2020.29","journal-title":"J Anim Res"},{"key":"10000_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/9781119294382.CH9","volume":"443","author":"LJ Larson","year":"2021","unstructured":"Larson LJ, Schultz RD (2021) Canine and Feline Vaccinations and Immunology. Infect Dis Manag Anim Shelters 443:191\u2013220. https:\/\/doi.org\/10.1002\/9781119294382.CH9","journal-title":"Infect Dis Manag Anim Shelters"},{"key":"10000_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/J.IMMUNI.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS (2019) Shared and distinct functions of type I and type III interferons. Immunity 50:907\u2013923. https:\/\/doi.org\/10.1016\/J.IMMUNI.2019.03.025","journal-title":"Immunity"},{"key":"10000_CR17","doi-asserted-by":"publisher","unstructured":"Mia M, Hasan M, Mia MM (2021) Update on Canine Parvovirus Infection\u202f: A Review from the Literature Effects of Perch Availability on broiler chicken with meat quality parameter View project Canine Parvovirus and its mitigation Strategy in Free Roaming Dogs View project. https:\/\/doi.org\/10.17582\/journal.vsrr\/2021.7.2.92.100","DOI":"10.17582\/journal.vsrr\/2021.7.2.92.100"},{"key":"10000_CR18","doi-asserted-by":"publisher","first-page":"105648","DOI":"10.1016\/J.TVJL.2021.105648","volume":"271","author":"RS Mueller","year":"2021","unstructured":"Mueller RS, Hartmann K (2021) Interferon therapies in small animals. Vet J 271:105648. https:\/\/doi.org\/10.1016\/J.TVJL.2021.105648","journal-title":"Vet J"},{"key":"10000_CR19","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/J.IMMUNI.2005.03.007","volume":"22","author":"A Murphy","year":"2005","unstructured":"Murphy A, Westwood JA, Teng MWL et al (2005) Gene modification strategies to induce tumor immunity. Immunity 22:403\u2013414. https:\/\/doi.org\/10.1016\/J.IMMUNI.2005.03.007","journal-title":"Immunity"},{"key":"10000_CR20","doi-asserted-by":"publisher","unstructured":"Negishi H, Taniguchi T, Yanai H (2018) The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. https:\/\/doi.org\/10.1101\/cshperspect.a028423","DOI":"10.1101\/cshperspect.a028423"},{"key":"10000_CR21","doi-asserted-by":"publisher","first-page":"e1007420","DOI":"10.1371\/JOURNAL.PPAT.1007420","volume":"14","author":"K Pervolaraki","year":"2018","unstructured":"Pervolaraki K, RastgouTalemi S, Albrecht D et al (2018) Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLoS Pathog 14:e1007420. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1007420","journal-title":"PLoS Pathog"},{"key":"10000_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/0300985813511129","volume":"51","author":"PA Pesavento","year":"2014","unstructured":"Pesavento PA, Murphy BG (2014) Common and emerging infectious diseases in the animal shelter. Vet Pathol 51:478\u2013491. https:\/\/doi.org\/10.1177\/0300985813511129","journal-title":"Vet Pathol"},{"key":"10000_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3201\/EID2702.202452","volume":"27","author":"AD Radford","year":"2021","unstructured":"Radford AD, Singleton DA, Jewell C et al (2021) Outbreak of severe vomiting in dogs associated with a canine enteric coronavirus, United Kingdom. Emerg Infect Dis 27:517. https:\/\/doi.org\/10.3201\/EID2702.202452","journal-title":"Emerg Infect Dis"},{"key":"10000_CR24","doi-asserted-by":"publisher","unstructured":"Scott-Morris B, Walker D (2015) Nursing the patient with parvovirus. new pub: Salt Media\/Latcham 31:25\u201329. https:\/\/doi.org\/10.1080\/17415349.2015.1107517","DOI":"10.1080\/17415349.2015.1107517"},{"key":"10000_CR25","doi-asserted-by":"publisher","unstructured":"Tizard IR (2021) Canine vaccines. Vaccines Vet 153. https:\/\/doi.org\/10.1016\/B978-0-323-68299-2.00022-8","DOI":"10.1016\/B978-0-323-68299-2.00022-8"},{"key":"10000_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2007.07.024","volume":"369","author":"JQH Wu","year":"2007","unstructured":"Wu JQH, Barab\u00e9 ND, Huang YM et al (2007) Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 369:206\u2013213. https:\/\/doi.org\/10.1016\/j.virol.2007.07.024","journal-title":"Virology"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-022-10000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-022-10000-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-022-10000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:41:10Z","timestamp":1669182070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-022-10000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,26]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10000"],"URL":"https:\/\/doi.org\/10.1007\/s11259-022-10000-1","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,26]]},"assertion":[{"value":"28 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}